A phase 2, placebo-controlled, randomized, double-blind trial of tozadenant (Syn-115) in patients with Parkinson's disease with wearing-off fluctuations on levodopa

✍ Scribed by Hauser, R.A.; Olanow, C.W.; Kieburtz, K.D.; Neale, A.; Resburg, C.; Meya, U.; Bankak, S.I.

• Book ID: 123114280
• Publisher: Elsevier Science
• Year: 2013
• Tongue: English
• Weight: 61 KB
• Volume: 333
• Category: Article
• ISSN: 0022-510X
• DOI: 10.1016/j.jns.2013.07.400